1![------------------------DOSAGE AND ADMINISTRATION---------------------Rheumatoid Arthritis Recommended dose of XELJANZ is 5 mg twice daily. (2.1) Moderate and severe renal impairment and moderate hepatic impairme ------------------------DOSAGE AND ADMINISTRATION---------------------Rheumatoid Arthritis Recommended dose of XELJANZ is 5 mg twice daily. (2.1) Moderate and severe renal impairment and moderate hepatic impairme](https://www.pdfsearch.io/img/f23efa8c5a983e3581cf3bb5d883a435.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2015-06-22 13:44:18
|
---|
2![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use COSENTYX safely and effectively. See full prescribing information for COSENTYX. ---------------------------------CO HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use COSENTYX safely and effectively. See full prescribing information for COSENTYX. ---------------------------------CO](https://www.pdfsearch.io/img/20f046654691fb57d08fed91b1023626.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2015-01-22 14:01:35
|
---|
3![Horizon Scanning Technology Prioritising Summary Home ultraviolet B (UVB) phototherapy for the treatment of severe psoriasis March 2010 Horizon Scanning Technology Prioritising Summary Home ultraviolet B (UVB) phototherapy for the treatment of severe psoriasis March 2010](https://www.pdfsearch.io/img/43bf18a8c6acb2121dbab8b25d636cb7.jpg) | Add to Reading ListSource URL: www.horizonscanning.gov.auLanguage: English - Date: 2011-04-06 22:10:09
|
---|
4![HIGHLIGHTS OF PRESCRIBING INFORMATION HIGHLIGHTS OF PRESCRIBING INFORMATION](https://www.pdfsearch.io/img/12ca01811c04d5e1367f477c3f0151a2.jpg) | Add to Reading ListSource URL: www.genzyme.comLanguage: English - Date: 2015-03-03 10:30:18
|
---|
5![achanA September 12, 2007 Astellas Initiates Phase II Clinical Trials for Immunosuppressant, ASP0485 achanA September 12, 2007 Astellas Initiates Phase II Clinical Trials for Immunosuppressant, ASP0485](https://www.pdfsearch.io/img/9146023eda06e0b02837420da84cf567.jpg) | Add to Reading ListSource URL: www.astellas.comLanguage: English - Date: 2008-09-18 20:52:49
|
---|
6![For More Information Contact: MEDIA CONTACTS: Maribeth Landwehr Astellas US LLC Ph: [removed]removed] For More Information Contact: MEDIA CONTACTS: Maribeth Landwehr Astellas US LLC Ph: [removed]removed]](https://www.pdfsearch.io/img/4a63262e36946590f09ff2c6d926b799.jpg) | Add to Reading ListSource URL: www.astellas.comLanguage: English - Date: 2008-09-19 01:05:58
|
---|
7![1 Version Oct[removed]What can you do to manage your psoriasis? A decision aid for psoriasis patients 1 Version Oct[removed]What can you do to manage your psoriasis? A decision aid for psoriasis patients](https://www.pdfsearch.io/img/cbd54d393ac89833b63347af2ea15810.jpg) | Add to Reading ListSource URL: www.healthyimage.caLanguage: English - Date: 2012-10-29 12:12:39
|
---|
8![Alefacept (Amevive) Clinical Review Alefacept (Amevive) Clinical Review](https://www.pdfsearch.io/img/acf0b9a13d0d2bf92270f7dcf45574ad.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
9![Alefacept (Amevive) Reveiw Alefacept (Amevive) Reveiw](https://www.pdfsearch.io/img/acb341c3afaee99aed6292a5a12ef41e.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
10![CDA Abstracts Oral Presentations Periocular Swelling as a Manifestation of Melkersson-Rosenthal Syndrome Anwar Al Hammadi; Denis Sasseville; McGill University, Montreal, QC, Canada CDA Abstracts Oral Presentations Periocular Swelling as a Manifestation of Melkersson-Rosenthal Syndrome Anwar Al Hammadi; Denis Sasseville; McGill University, Montreal, QC, Canada](https://www.pdfsearch.io/img/bb99f29c0bd8a14d9e5c22dbca613986.jpg) | Add to Reading ListSource URL: www.dermatology.caLanguage: English - Date: 2012-06-07 05:58:41
|
---|